Skip to content

Preoperative oral administration of Shenjiangqing drink to promote enhanced recovery in the perioperative period of total knee arthroplasty: a prospective, randomized controlled trial protocol.

Preoperative oral administration of Shenjiangqing drink to promote enhanced recovery in the perioperative period of total knee arthroplasty: a prospective, randomized controlled trial protocol.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001334
Enrollment
Unknown
Registered
2026-05-26
Start date
2025-08-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedic-related diseases

Interventions

Experimental Group:Take the ginseng and ginger drink orally 3 hours before surgery.
Control Group:Take Shunengqing drink orally 3 hours before surgery.

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine, Ersha Island Hospital, Department of Sports Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with OA (knee osteoarthritis) according to the diagnostic criteria published by the American Rheumatism Association (ARA) in the "Diagnostic Criteria for Knee Osteoarthritis," and who meet the diagnostic standards of traditional Chinese medicine during the perioperative period. 2. Patients of any gender, aged between 50 and 75 years, who have been assessed and are scheduled to undergo unilateral total knee arthroplasty (TKA). 3. All patients are operated on by the same surgical team and anesthesiologist, using the same prosthetic implant and endotracheal intubation anesthesia. 4. Patients who voluntarily participate in this trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Diabetic patients 2. Individuals with a history of delayed gastric emptying, gastroesophageal reflux, or other conditions affecting gastric emptying 3. Allergic patients to the components of the investigational drug 4. Patients with a history of anxiety or chronic hypoproteinemia 5. Individuals with autoimmune diseases and recent use of corticosteroids 6. Other conditions deemed inappropriate for inclusion by the investigator

Design outcomes

Primary

MeasureTime frame
Christensen Fatigue Scale;

Secondary

MeasureTime frame
Fatigue Scale FS-14;Insulin Resistance Index (HOMA-IR);Gastric ultrasound measurement of the gastric antrum area.;WHO Nausea and Vomiting Grading;hemoglobin;Serum transferrin;Prealbumin (PA);C-reactive protein (CRP);Superoxide Dismutase;

Countries

China

Contacts

Public ContactDa Guo

Guangdong Provincial Hospital of Traditional Chinese Medicine, Ersha Island Branch Hospital, Department of Sports Medicine

David.Guo.D@gzucm.edu.cn13926464394

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026